Podcasts about Indication

Comment aider vos enfants à GRANDIR sans les blesser ni les flatter ? Dans cet épisode captivant de "Princesse Montessori", Xénia Troubetzkoï nous plonge dans l'univers du FEEDBACK CONSTRUCTIF. Ce retour d'information est essentiel pour accompagner nos enfants sur le chemin de l'apprentissage. Mais comment formuler ce feedback de manière efficace ? Xénia nous révèle une méthode en trois étapes qui transforme notre approche éducative. Voici les trois composantes clés d'un FEEDBACK EFFICACE :Observation factuelle : Commencez par décrire ce que vous avez observé sans jugement. Reconnaissance de l'effort : Soulignez l'effort ou la stratégie utilisée par l'enfant. Indication du prochain pas : Proposez une direction claire pour la suite. Ce type de retour d'information permet de réduire la pression sur les enfants. Il recentre leur attention sur l'apprentissage et les encourage à passer à l'action. Xénia partage également des EXEMPLES PRATIQUES de feedback dans différents CONTEXTES ÉDUCATIFS, illustrant comment ces principes peuvent être appliqués au quotidien. En restant concis et en se concentrant sur une seule amélioration à la fois, nous pouvons véritablement transformer la manière dont nos enfants reçoivent le feedback. Ce processus les aide non seulement à se sentir soutenus, mais aussi à DEVELOPPEMENT leurs compétences de manière autonome. À la fin de l'épisode, Xénia lance un défi aux auditeurs : tester cette méthode de feedback en trois temps avec leurs enfants et observer les résultats. Êtes-vous prêt à faire évoluer votre approche éducative ? Rejoignez-nous pour découvrir comment le FEEDBACK CONSTRUCTIF peut devenir un outil puissant dans votre boîte à outils de parent. Écoutez dès maintenant cet épisode inspirant de "Princesse Montessori" et transformez la manière dont vous interagissez avec vos enfants. Ensemble, faisons de l'apprentissage une expérience JOYEUSE et ENRICHISSANTE !

Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this special edition of Mind Moments, Patricia Pozo-Rosich, MD, PhD, head of the neurology department at Vall d'Hebron University Hospital, discussed the recent FDA approval of fremanezumab (Ajovy) for pediatric migraine prevention. As a study author on the pivotal phase 3 SPACE trial (NCT03539393), Dr. Pozo-Rosich reflected on the significance of having a proven therapeutic option in a population where placebo responses and lack of evidence have long complicated care. She provided insights on how the trial was designed and the challenges of running pediatric studies, particularly in adolescents. Additionally, she highlighted broader implications for migraine research, including efforts to reduce placebo effects, the role of CGRP pathway inhibition in younger patients, and the future promise of emerging targets such as PACAP antagonists and new toxin formulations. For more of NeurologyLive's coverage of fremanezumab's expanded indication in pediatric migraine, head here: FDA Approves Fremanezumab as First Anti-CGRP Preventive Therapy for Pediatric Episodic Migraine Episode Breakdown: 1:10 – Initial reaction to fremanezumab approval and significant for pediatric migraine care 6:05 – Major clinical insights and takeaways from phase 3 SPACE trial 10:20 – Challenges in pediatric migraine trials and addressing high placebo responses 15:10 – Future directions in migraine therapy, including PACAP-targeting drugs and novel approaches Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

"McElroy & Cubelic In The Morning" airs 7am-10am weekdays on WJOX-94.5!See omnystudio.com/listener for privacy information.

Listen to a conversation with Durand Jones, Aaron Frazer and Blake Rhein of the soul band Durand Jones and The Indications. They joined WFYI's Kyle Long for an in-depth discussion of their roots in Bloomington, Indiana and how projects including the IU Soul Revue and Charlie Patton's War brought the band together. The Indications' latest album is titled “Flowers”, and they'll be performing in Indianapolis on September 30 at the Hi-Fi Annex.  Durand Jones and the Indications formed in Bloomington in 2012, while its members were studying at Indiana University. The band's sound was built around a mutual love for classic soul, funk and R&B. Their reputation spread beyond Bloomington in 2016, when Ohio's Colemine Records issued their debut album. The Indication's second album “American Love Call” was issued in 2019 and praised by critics for its lush arrangements and socially conscious lyrics, earning comparisons to The Impressions and The Delfonics. Two years later, their album “Private Space” debuted in the Top 10 of Billboard's Emerging Artists chart. Their latest album “Flowers” builds on the band's distinct blend of vintage soul sounds and contemporary production techniques. Since launching in Bloomington over a decade ago, The Indications have grown into an international force, racking up millions of streams online, and touring across North America and Europe.

Texts, eng_t_rav_2025-08-30_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 1

Audio, eng_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Audio, eng_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Video, eng_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, eng_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Audio, eng_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Audio, eng_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, eng_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, eng_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Audio, por_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Texts, eng_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 1

Video, ron_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, ron_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Video, por_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, por_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Video, hun_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, hun_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Audio, por_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Audio, bul_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, bul_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, por_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, por_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Audio, eng_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Video, fre_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Video, eng_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Video, fre_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Audio, eng_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Audio, bul_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Audio, hun_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Audio, hun_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Video, eng_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, hun_t_rav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, hun_t_norav_2025-08-31_lesson_bs-shamati-056-tora-nikra-yore_n2_p1. Lesson_part :: Lessons_series. Baal HaSulam. Shamati, 56. Torah Is Called Indication :: Daily_lesson 2

Audio, eng_t_rav_2025-08-30_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, eng_t_rav_2025-08-30_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Audio, eng_t_rav_2025-08-30_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, eng_t_rav_2025-08-30_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Audio, bul_t_rav_2025-08-30_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, fre_t_rav_2025-08-30_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

Video, hun_t_rav_2025-08-30_lesson_bs-shamati-056-tora-nikra-yore_n1_p1. Lesson_part :: Daily_lesson 1

After shoplifting $1500 worth of merchandise, including 21 bottles of probiotics, from three different pharmacies, 32-year-old Tyler Jones was pulled over for riding his bike at night without a light. HE thought they wanted him for the thefts, which they did when the first thing he said was "I didn't do it."See omnystudio.com/listener for privacy information.

Hear Christopher McKim's journey with moderate to severe plaque psoriasis and the latest clinical trial results from dermatologist, Dr. Christine Cornejo. Join this discussion with moderator Archie Franklin as Christopher McKim, a BMS employee living with moderate to severe plaque psoriasis, and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at BMS, offer a patient and physician's perspective on treating plaque psoriasis from the inside. Listen as Chris presents his journey along with Dr. Cornejo addressing effectiveness and safety information with clinical trial results for a prescription oral treatment option. The intent of this episode is to encourage those who have moderate to severe plaque psoriasis to work with their health care provider to find a treatment option that is right for them. This episode is sponsored by Bristol Myers Squibb. For more information view Full Prescribing Information and Medication Guide . ·       (0:00)   Intro to Psoriasis Uncovered and guest welcome to Bristol Myers Squibb employee and patient Christopher McKim and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at Bristol Myers Squibb. ·       (2:15)  Where the journey to finding the right treatment option for Chris and his moderate to severe plaque psoriasis began.  ·       (3:09)   The decision by Chris and his provider to try an oral systemic medication. ·       (3:28)  The effects and impact of an oral systemic treatment for Chris and his plaque psoriasis. ·       (4:09)   Dr. Cornejo addresses efficacy and clinical trials results. ·       (5:58)   Common side effects and safety concerns for the treatment Chris and his health care provider decided to try.   ·       (6:28)   Health considerations patients and providers should discuss prior to using a systemic treatment.    ·       (6:54)   What to do should side effects occur. ·       (7:10)   How Chris feels with clearer skin after making a change in treatment. ·       (8:14)   Indication and Important Safety Information. Key Takeaways: ·       Moderate to severe plaque psoriasis is a systemic disease.    ·       If you're ready to treat from the inside there is a treatment option that may help.   ·       Work with a health care provider to find the right treatment for moderate to severe plaque psoriasis.   ·       Be proactive by taking steps to learn about treatment options including effectiveness, side effects, safety concerns, and what should be discussed with a health care provider before beginning a new treatment for plaque psoriasis.  Guest Bios:   Christopher (Chris) McKim joined BMS in June of 2022. In his current role he is a Regional Marketer for the dermatology division, prior to that he provided support for 9 Therapeutic Area Specialists for the Pacific South District in the GI division.  Prior to joining BMS, Chris worked at Sanofi, J&J, Leo Pharma, and Sun Pharma in various field and home office roles. Chris resides in beautiful San Diego with his family Susan (wife), Morgan 18, Maddy 16, Mason 14 and two Golden Retrievers and enjoys traveling, cooking and anything associated with the ocean (Deep Sea Fishing, S.C.U.B.A. diving, snorkeling, and boogie boarding). Dr. Christine Cornejo joined Bristol Myers Squibb in 2024 as Director, Medical Engagement Lead for Dermatology and Rheumatology. Prior to joining BMS, she practiced dermatology at Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, MA, where she specialized in melanoma and high-risk skin cancer management and served as the Director of Confocal Microscopy. She also served as an Instructor at Harvard Medical School and led the Immunology and Infectious Diseases course for 1st year medical students. Resources: Current Oral Systemic Treatments For additional questions about treatment options contact the NPF Patient Navigation Center

New indication for Kerendia; investigational therapy shows promise for hypertension; Novolog interchangeable biosimilar gets approval; trial results for hormone-free contraceptive; Shingrix now supplied in a prefilled syringe.

Mike Johnson, Beau Morgan, and Ali Mac continue the final hour by spending some time with 92.9 The Game's own Braves insider and reporter, Grant McAuley! Beau, Mike, Ali, and Grant discuss if Grant thinks the Braves could trade Sean Murphy at the trade deadline, what Grant expects from the Braves after the All-Star break, how Grant felt about Spencer Strider's start last night, Grant Holmes putting together a really good 2025 season, Grant Holmes not getting any run support this season, what Grant is most excited about for All-Star Weekend here in Atlanta, and who Grant is looking forward to talking to the most out of all of the 2025 MLB All-Stars.

Matthew 25:31–46

Phil Steele top 60 has Utah at #18 and BYU at #53 60 in 60 Watchlist - Broc Lane - USU TE | Good, Bad & Ugly Whole World News